Aaron Baillie

Clean energy and hydrogen policy frameworks and related federal innovation, industrial, and funding programs, with respect to eligibility criteria, definitions, standards, and policy directions affecting advanced propulsion technologies, hydrogen applications, advanced manufacturing, and defence-adjacent innovation, including engagement related to federal programs, pilot projects, and partnership initiatives supporting clean technology development and commercialization.

Discussions regarding digital policy and legislation, including as it relates to artificial intelligence (AI) and data protection, privacy and reduction of online harms. AI adoption including updating procurement policies. Discuss issues related to international competitiveness of the domestic AI industry. Provide subject matter (AI) expertise to the Canadian AI Safety Institute team where it might be helpful across a number of areas including opportunities for research and safety practices. Discussions with officials regarding the Canada-US bilateral relationship.

Temporary Foreign Worker Program - with respect to meeting the needs of Canada's emerging technology-based businesses. National Research Council Canada – Industrial Research Assistance Program – with respect to funding programs supporting small-medium and large sized (SMEs) enterprises Invest Canada - with respect to attracting foreign investors in digital media, information, communications and technology companies International Science and Technology Partnership Program – with respect to exchanging knowledge between Canadian companies and foreign countries Income Tax Act - Amendment to the Income Tax Act with respect to angel investors Global Opportunites for Associations - with respect to facilitating SME experience aboard FedDev Ontario - Regional Innovation Ecosystem Program – with respect to scaleup platform work Employment and Social Development Canada - Opportunities to fund skills and training programs in Waterloo Region Centre of Excellence in Research and Commercialization - with respect to bringing new technologies to market to create more companies, jobs and wealth in Canada. Building in Canada Fund - with respect to Two-way Go Train service linking Waterloo Region to the Greater Toronto Area

National Semiconductor Strategy: explaining our firms use of semiconductor manufacturing technologies from foreign suppliers, and encouraging the federal government to invest in domestic production capabilities for silicon photonic integrated circuits. National Quantum Computing Strategy - explaining our firms plans for cooperation with the Canadian public and private sectors to explore quantum computing through a sandbox or publicly supported virtual platform, and requesting government support. Requesting more education and training around quantum computing. Explaining our long term plan to build large scale quantum computers in Canada.

Communicating with the Government of Canada about Bill C-8 (An Act respecting cyber security, amending the Telecommunications Act and making consequential amendments to other Acts). Communicating with the Government of Canada about Bill C-22 (An Act respecting lawful access) Communicating with the Government of Canada about Bill formerly known as C-27 (Digital Charter Implementation Act, 2022), more specifically the creation of the Artificial Intelligence and Data Act. Communicating with the Government of Canada about Bill C-2 (An Act respecting certain measures relating to the security of the border between Canada and the United States and respecting other related security measures). Work with government to promote and support Canada’s digital economy, including ensuring the availability of a high-skilled tech workforce. Seeking to influence policy direction related to cloud based services. Seeking government contract with multiple government departments and institutions with regards to Amazon Cloud based solutions and related support services.

Looking to engage on policies and programs under development related to the adoption and deployment of data analytics, artificial intelligence, and digital infrastructure solutions across federal departments, agencies, and municipalities. Opportunities to provide funding around transportation, economic, and planning-based data analytics to inform government decision-making

Tourism and cultural events: advancing Toronto and Ontario as destinations for international business, innovation, and cultural exchange through the delivery of large-scale technology events and festivals. Lobbying activities relate to government support for events that drive visitor attraction, hotel stays, local spending, and global visibility, while strengthening the province’s reputation as a hub for innovation, entrepreneurship, and creative industries. Public funding and policy support enable the production of festivals and convenings that generate economic impact, support local suppliers and venues, and contribute to year-round tourism activity. Economic development: supporting the growth of the regional innovation ecosystem through programs, events and dialogue. These also include connecting partners in the development of stronger economic ecosystems, building talent to support the tech and digital economies and festivals bringing together people for the exchange of ideas. Grant funding will be used to support programs that support talent development, events to support the growth of the innovation ecosystem through business networking and training, and the systems to support these initiatives

Regulations, policies and programs related to the reimbursement recommendations decision-making process and framework done by the Canadian Agency for Drugs and Technologies in Health (CADTH)/Common Drug Review as well as the review times and processes conducted by Health Canada for the purpose of obtaining a notice of compliance. National Strategy for Drugs for Rare Disease as it relates to separate regulatory pathways for drugs for rare diseases and the government strategy. Monitoring and engaging the Government and Parliamentarians on policies and programs that would provide greater clarity and predictability in the tax outcomes and improvements to tax measures such as the Manufacturing & Processing (M&P) credit and the Scientific Research & Developmental (SR&ED). Common Drug Review Policies as it relates to reimbursement recommendation decision-making process and framework. Federal Public Drug Plans, with respect to the reimbursement of therapeutic products for Federal plan beneficiaries Policies related to the National Strategy for Drugs for Rare Disease as it relates to separate regulatory pathway for drugs for rare diseases and the government strategy. Policies related to Subsequent Entry Biologics (SEBs) pertaining to Draft Guidance for Sponsors; Information and Submission requirements for SEBs, regulations and intellectual property policies, naming conventions Monitoring and engaging on the Government’s commitment (Budget, SFT, Fall Economic Update) to create a national strategy for drugs for rare diseases; create a new Canadian Drug Agency; and the implementation of national, universal pharmacare. Pharmaceutical policy and any negotiations of a Health Accord or agreement with the Provinces/Territories, as it relates to National Pharmacare/universal or catastrophic drug coverage, Drug policies & Pricing. The Department of Innovation, Science and Economic Development and the Innovation Agenda for the life sciences sector: policy or program initiatives to support life science research and development conducted in Canada and manufacturing capability, and as it relates to Canada’s Biomanufacturing and Life Sciences Strategy. Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's biomanufacturing and life sciences sector strategy National Pharmacare (Bill C-64, An Act respecting pharmacare) Canadian Environmental Protection Act and Regulations in respect of modern, science-based regulations to reflect rapidly changing new technologies. Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products. Income Tax Act as it relates to biopharmaceutical industry. Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry, and related updates and to Federal budgetary policy. Discussions around the World Trade Organization consideration of a TRIPS Patent Waiver - Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility". The Food and Drugs Act, or the Export and Imports Permits Act (Export Control List) or any other legislative and regulatory means in order to protect the Canadian supply of drugs in light of importation legislation in the United States. Standing Committee on Finance (FINA) as it relates to pre-budget consultations. Pharmaceutical intellectual property protection as it relates to international trade agreements Patent Act and Patented Medicines (Notice of Compliance) Regulations, as it relates to the regulation of intellectual property, approval for therapeutic products, changes to modernize the Right of Appeal House of Commons Standing Committee of Science and Research (SRSR) as it relates to Science in Canada and/or any other pertinent legislative proposal before the committee House of Commons Standing Committee of Industry and Technology (INDU) as it

À la recherche de subventions pour accroître les capabilités de l'organisation à répondre aux besoins technologiques dictées par les technologies de rupture émergentes et prometteuse pour soutenir et favoriser les transferts technologiques et atteindre les cibles de commercialisation ainsi que pour soutenir les activités de recherche-développement (R-D) collaborative, la recherche scientifique et le développement expérimental (RS&DE).

Quantum industrialization: Support for quantum R&D and commercialization funding for Canadian quantum companies. Monitoring, interaction and advocacy regarding policy and programs supporting the growth of Canadian startups by means of government procurement of research, development, prototype development and testing. Discussions with government officials regarding procurement through the Office of Digital Transformation, the Defence Procurement Agency, and new procurement vehicles as a result of the new federal government’s procurement reform policies